openPR Logo
Press release

US Genomic Biomarker Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027

09-06-2021 02:35 PM CET | Health & Medicine

Press release from: OMR REPORTS

The US genomic biomarker market is estimated to grow significantly at a CAGR of around 15.6% during the forecast period. Factors that are contributing significantly to the market growth include the presence of well-developed healthcare infrastructure, increasing healthcare R&D investments, high healthcare expenditure, and others.

A full report of US Genomic Biomarker Market is available at: https://omrreports.com/us-genomic-biomarker-market/48877/

Scope of the Report

• Comprehensive research methodology of the US Genomic Biomarker Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US Genomic Biomarker Market.
• Insights about market determinants that are stimulating the US Genomic Biomarker Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

To learn more about this report request a sample copy @ https://omrreports.com/request-sample/?id=48877

US Genomic Biomarker Market- Segmentation

By Application

• Oncology
• Cardiology
• Neurology
• Others

Company Profiles

• Abbott Laboratories Inc.
• Agilent Technologies, Inc.
• Banyan Biomarkers, Inc.
• Beckman Coulter Inc.
• Becton, Dickson, and Co.
• Bio-Rad Laboratories, Inc.
• Celgene Corp.
• Cofactor Genomics, Inc.
• Empire Genomics, LLC
• Enzo Life Sciences, Inc.

Media Contact:

Company Name: OMR REPORTS
Contact Person: Mr. Anurag Tiwari
Email: info@omrreports.com
Contact no: +91 780-304-0404

About OMR Reports

OMR Reports endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Genomic Biomarker Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027 here

News-ID: 2382727 • Views: 85

More Releases from OMR REPORTS

Electrocardiograph Market Report 2021: By Key Players, Type, Share and Forecast …
The global ECG market is expected to grow at a CAGR of 6.0% during the forecast period. Electrocardiograph (ECG) is a non-invasive medical test that tracks the electrical activities of the heartbeat over a period of time. According to WHO, cardiovascular diseases are among the major cause of mortality across the globe. Among all global mortalities, 31% of them are caused due to CVDs. To observe various information regarding heart
Disposable Medical Sensors Market to 2027, Future Outlook, COVID-19 Impact Analy …
The global disposable medical sensors market is projected to witness a considerable growth rate by exhibiting a significant CAGR of 10.1% during the forecast period. There are various key factors that are contributing to market growth, such as technological advancement in medical industry, increasing demand for remote patient monitoring devices, and rising geriatric population. A full report of Disposable Medical Sensors Market is available at: https://omrreports.com/disposable-medical-sensors-market/49213/ Scope of the Report The global disposable
Digital Pathology Market: Analysis Report, Share, Trends and Overview 2021-2027
The global digital pathology market is anticipated to grow at a significant CAGR during the forecast period. Digital pathology devices serve as important tools for pathologists. The accomplishments in the digital pathology field have improved the workflow of labs, thereby enhancing the pathologist’s role in diagnostics. In addition, digital pathology devices are majorly being used in the R&D of personalized targeted medications. Improvement has been witnessed in the performance of
Dialysis Equipment Market Trends, Research Report, Growth, Opportunities, Foreca …
The global dialysis equipment market is anticipated to grow with a significant CAGR of 6.1%, during the forecast period. Generally, dialysis is needed when end-stage kidney failure is developed, by this time the patient loses about 85-90% of their kidney functions and has a GFR (Glomerular filtration rate) of less than 15. Dialysis equipment uses a special fluid containing a mixture of pure water and chemicals to carefully eliminate the

All 5 Releases


More Releases for Genomic

Cardiology Genomic Testing Market Impact Analysis By 2028
Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases. Identification of genetic causes can save lives. The technology used for cardiology
Emerging Growth of Global Genomic Medicine Market to 2019-2025| Center for Genom …
Researchmoz (RMOZ) added Most up-to-date research on "Global Genomic Medicine Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. NHGRI defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care and the health outcomes and policy implications of that clinical use." Backed by government investments in precision medicine initiatives such as a multimillion dollar investment by
Global Genomic Biomarker Market Research and Forecast 2018-2023
“Increasing prevalence of chronic diseases and demand for advanced disease diagnostics is driving the growth of genomic biomarker market.” According to the OMR analysis, the global genomic biomarker market is growing at a moderate rate during 2018-2023. The global genomic biomarker market has witnessed a moderate growth due to increasing cases of chronic diseases and rising healthcare expenditure. The global genomic biomarker market is segmented on the basis of disease indication,
Genomic Medicine Market Detailed Analytical Overview by 2016 - 2026
The National Human Genome Research Institute defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use." Genomic medicine is a type of precision medicine in which genomics, epigenomics and other related data is used to accurately aid in individual disease diagnosis.
Global Genomic Sequencing Technologies Market US$ 7.2 Billion by 2021
The global genomic sequencing technologies market expected to reach US$ 7.2 billion by 2021, growing at CAGR 14% over the forecast period 2017-2021, mainly due to high-throughput - next generation sequencing technologies, and advances in personalized medicine. Genomic sequencing technologies have revolutionized biology, with impacts ranging from the sequencing of several model genomes to the birth of a new era for pharmacogenomics. In recent years, there has been an increasing fragmentation
Genomic Medicine Market Rugged Expansion Foreseen by 2026
The National Human Genome Research Institute defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use." Genomic medicine is a type of precision medicine in which genomics, epigenomics and other related data is used to accurately aid in individual disease diagnosis.